Pegasus Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.32M Hold
10,995
0.42% 39
2025
Q4
$1.16M Hold
10,995
0.36% 39
2025
Q3
$923K Sell
10,995
-1,424
-11% -$117K 0.3% 46
2025
Q2
$983K Buy
12,419
+553
+5% +$44K 0.34% 45
2025
Q1
$1.07M Sell
11,866
-23,760
-67% -$2.22M 0.43% 42
2024
Q4
$3.54M Buy
35,626
+475
+1% +$49K 1.34% 28
2024
Q3
$3.99M Buy
35,151
+103
+0.3% +$12.2K 1.52% 23
2024
Q2
$4.34M Sell
35,048
-132
-0.4% -$17K 1.66% 22
2024
Q1
$4.64M Buy
35,180
+324
+0.9% +$39.9K 1.8% 22
2023
Q4
$3.8M Buy
34,856
+15
+0% +$1.56K 1.63% 25
2023
Q3
$3.59M Buy
34,841
+474
+1% +$51.1K 1.67% 22
2023
Q2
$3.97M Sell
34,367
-542
-2% -$61.5K 1.77% 23
2023
Q1
$3.71M Buy
34,909
+220
+0.6% +$23.8K 1.84% 19
2022
Q4
$3.85M Buy
34,689
+49
+0.1% +$5.01K 2.08% 18
2022
Q3
$2.98M Sell
34,640
-266
-0.8% -$23.7K 1.69% 22
2022
Q2
$3.18M Sell
34,906
-81
-0.2% -$7.18K 1.73% 23
2022
Q1
$2.87M Buy
34,987
+119
+0.3% +$9.38K 1.25% 34
2021
Q4
$2.67M Buy
34,868
+564
+2% +$44.9K 1.1% 35
2021
Q3
$2.58M Buy
34,304
+1,346
+4% +$102K 1.18% 34
2021
Q2
$2.56M Sell
32,958
-1,272
-4% -$94.6K 1.2% 33
2021
Q1
$2.52M Buy
34,230
+1,841
+6% +$136K 1.28% 31
2020
Q4
$2.53M Buy
32,389
+8,644
+36% +$661K 1.39% 30
2020
Q3
$1.88M Sell
23,745
-279
-1% -$21.9K 1.18% 33
2020
Q2
$1.77M Buy
24,024
+514
+2% +$38.7K 1.21% 35
2020
Q1
$1.73M Buy
23,510
+252
+1% +$19.8K 1.42% 31
2019
Q4
$2.02M Buy
23,258
+398
+2% +$32.7K 1.33% 32
2019
Q3
$1.84M Buy
22,860
+194
+0.9% +$15.5K 1.34% 33
2019
Q2
$1.81M Sell
22,666
-603
-3% -$46.2K 1.4% 31
2019
Q1
$1.85M Buy
23,269
+28
+0.1% +$2.09K 1.52% 31
2018
Q4
$1.7M Sell
23,241
-111
-0.5% -$7.84K 1.6% 29
2018
Q3
$1.58M Sell
23,352
-663
-3% -$42.2K 1.32% 35
2018
Q2
$1.39M Buy
24,015
+1,175
+5% +$66.3K 1.3% 34
2018
Q1
$1.19M Buy
22,840
+915
+4% +$49.4K 1.13% 38
2017
Q4
$1.18M Buy
+21,925
New +$1.22M 1.18% 37

Other funds holding MRK

Pegasus Asset Management's MRK Position: Q1 2026 in Review

Pegasus Asset Management held its Merck (MRK) position steady in Q1 2026 at 10,995 shares worth $1.32M. The position accounts for 0.42% of the portfolio, ranked #39.

Pegasus Asset Management first reported a position in MRK in Q4 2017 and has held it in 34 quarters since. The position peaked at $4.64M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Pegasus Asset Management held 10,995 shares of Merck worth $1.32M as of Q1 2026.
  • Pegasus Asset Management left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.42% of Pegasus Asset Management's portfolio in Q1 2026, its #39 holding.
  • Pegasus Asset Management first reported a position in Merck in Q4 2017 and has held it in 34 quarters since.
  • Pegasus Asset Management's Merck position peaked at $4.64M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Pegasus Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.